 DiaMedica Therapeutics Inc. NASDAQ:DMAC Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Rick Pauls - President and Chief Executive Officer Kirsten Gruis - Chief Medical Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets Alexander Nowak - Craig-Hallum Capital Group Francois Brisebois - Oppenheimer Co. Inc. Elemer Piros - ROTH Capital Partners Operator Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2022 Conference Call. An audio recording of the webcast would be available shortly after the call today on DiaMedicas website at in the Investor Relations section. 